NBY Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 mai 2024 @ 22:00):

Stats
Dagens volum	9.14M
Gjennomsnittsvolum	8.54M
Markedsverdi	5.33M
EPS	$0 ( 2024-05-28 )
Neste inntjeningsdato	( $-0.0300 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0400
ATR14	$0.00100 (0.71%)

Insider Trading

Date	Person	Action	Amount	type
2023-06-09	Freiman Paul E.	Buy	858	Restricted Stock Units
2023-06-09	Garlikov Julie	Buy	858	Restricted Stock Units
2023-06-09	Zheng Yenyou	Buy	858	Restricted Stock Units
2023-06-09	Zheng Yongxiang	Buy	858	Restricted Stock Units
2023-06-09	Sit Swan	Buy	858	Restricted Stock Units

INSIDER POWER
-70.40
Last 96 transactions
Buy: 2 335 940 \| Sell: 2 184 002

Volum Korrelasjon

Lang: 0.06 (neutral)

Kort: 0.98 (very strong)

Signal:(39.847) Expect same movement, but be aware

NovaBay Pharmaceuticals Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

NovaBay Pharmaceuticals Korrelasjon - Valuta/Råvare

0.00
( neutral )

0.67
( moderate )

NovaBay Pharmaceuticals Økonomi

Annual	2023
Omsetning:	$14.73M
Bruttogevinst:	$7.90M (53.61 %)
EPS:	$-2.29

FY	2023
Omsetning:	$14.73M
Bruttogevinst:	$7.90M (53.61 %)
EPS:	$-2.29

FY	2022
Omsetning:	$14.40M
Bruttogevinst:	$7.78M (54.02 %)
EPS:	$-10.10

FY	2021
Omsetning:	$8.42M
Bruttogevinst:	$5.65M (67.03 %)
EPS:	$-9.42

Financial Reports:

No articles found.

NovaBay Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.